Beyond Air (NASDAQ:XAIR) is focused on developing innovative medical devices and therapies aimed at transforming treatment options for patients with lung diseases and severe infections. The company has a diverse portfolio of projects, including advanced systems for Nitric Oxide delivery that target a range of medical conditions, from chronic lung infections to certain types of cancer. Beyond Air's objectives are centered around harnessing the therapeutic potential of Nitric Oxide to offer safer, more effective treatments, and improving patient outcomes across the globe. Aiming to push the boundaries of medical science, Beyond Air is committed to research, development, and commercialization of cutting-edge medical technologies.